This technology is a therapeutic approach that uses nicotinamide, a neuroprotective agent, to prevent glaucoma progression and associated vision loss by reducing intraocular pressure (IOP) and preserving retinal ganglion cells.
This technology is a soft-skinned anthropomorphic facial robot, Emo, designed to display a wide range of nuanced facial expressions, enhancing the quality of human-robot interactions.